Hospital Universitario de Getafe -ko ikertzaileekin lankidetzan egindako argitalpenak (10)

2024

  1. Identification of miRNAs and Their Target Genes Associated with Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Patients

    International Journal of Molecular Sciences, Vol. 25, Núm. 13

  2. The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2021

  1. (Pro)renin receptor is a novel independent prognostic marker in invasive urothelial carcinoma of the bladder

    Cancers, Vol. 13, Núm. 22

  2. Soluble pd-l1 is an independent prognostic factor in clear cell renal cell carcinoma

    Cancers, Vol. 13, Núm. 4, pp. 1-17

2020

  1. Altered tissue and plasma levels of fibroblast activation protein-α (FAP) in renal tumours

    Cancers, Vol. 12, Núm. 11, pp. 1-16

2019

  1. The coexpression of fibroblast activation protein (FAP) and basal-type markers (CK 5/6 and CD44) predicts prognosis in high-grade invasive urothelial carcinoma of the bladder

    Human Pathology, Vol. 91, pp. 61-68

2018

  1. High levels of intratumor heterogeneity characterize the expression of epithelial-mesenchymal transition markers in high-grade clear cell renal cell carcinoma

    Annals of Diagnostic Pathology, Vol. 34, pp. 27-30

2016

  1. Low-grade metastases in high-grade clear cell renal cell carcinomas A clinicopathologic study of 4 cases with an insight into the role of mesenchymal-to-epithelial transition process

    Annals of Diagnostic Pathology, Vol. 20, pp. 13-18

  2. The expression of fibroblast activation protein in clear cell renal cell carcinomas is associated with synchronous lymph node metastases

    PLoS ONE, Vol. 11, Núm. 12

2015

  1. The normal and pathologic renal medulla: A comprehensive overview

    Pathology Research and Practice, Vol. 211, Núm. 4, pp. 271-280